Open tender · Germany · Pharmaceutical products
Offene Rahmenvereinbarung über Arzneimittelrabatte gemäß § 130a Abs.8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sog. Zulassungsmodell 2026-09
In EnglishOpen framework agreement on drug discounts according to § 130a para. 8 SGB V with the possibility of joining at any time, so-called admission model 2026-09
Deutsche Rentenversicherung Knappschaft-Bahn-See
Deutsche Rentenversicherung Knappschaft-Bahn-See in Germany is inviting bids for “Open framework agreement on drug discounts according to § 130a para. 8 SGB V with the possibility of joining at any time, so-called admission model…”. Bids close on 5 July 2028, 23:59 CEST. askTender lists every requirement to qualify and checks whether your company meets them.
The work
Abschluss von Rabattverträgen für pharmazeutische Unternehmer für die Wirkstoffe Amlodipin/ Indapamid/ Perindopril, Anakinra, Brivaracetam, Brodalumab, Capsaicin, Dexketoprofen, Edoxaban, Fentanyl, Galcanezumab, Guanfacin, Liraglutid, Naproxen/ Esomeprazol, Nitisinon, Olodaterol/ Tiotropiumbromid, Pomalidomid, Rifaximin, Risedronsäure/ Calcium/ Colecalciferol, Risperidon, Sarilumab, Tafluprost/ Timolol, Telmisartan/ Amlodipin, Tinzaparin, Tiotropiumbromid, Trastuzumab/ Pertuzumab, Trifluridin/ Tipiracil.
Key facts
- Procedure
- Contract notice
Before you bid, askTender
Everything else is in your askTender account
askTender has broken this tender down into 4 requirements to qualify (2 on experience, 2 certifications and registrations) and the 2 documents a bidder must file.
- What it takes to qualify: every requirement, in the tender’s own words
- Whether your company qualifies: your profile checked against each requirement, showing what you have, what’s missing and how to close the gap
- The documents to file: a checklist, with draft declarations ready to sign
- A bid partner for any requirement you can’t meet alone
- The tender documents, ready to open
- Alerts for new tenders like this one
Public data: TED – Tenders Electronic Daily. © European Union, 1998–2026. Notices reused under Commission Decision 2011/833/EU. · Sources & licences